AnaptysBio, Inc. (NASDAQ: ANAB) reported Q2 EPS of $5.11, $5.24 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $27.5 million versus the consensus estimate of $20.22 million.

For earnings history and earnings-related data on AnaptysBio, Inc. (ANAB) click here.